Suchergebnisse - "Rochais, Christophe"

PubPharm (8)

1

Desirable drug-drug interactions or when a matter of concern becomes a renewed therapeutic strategy

enthalten in: Drug discovery today | 2021

von Guieu, B. | Jourdan, J. | Dreneau, A. | +3

2

3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression

enthalten in: European journal of medicinal chemistry | 2016

von Rizza, P. | Pellegrino, M. | Caruso, A. | +12

3

Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities

enthalten in: Anti-cancer agents in medicinal chemistry | 2015

von de Fatima Pereira, M. | Rochais, C. | Dallemagne, P.

4

MR22388, a novel anti-cancer agent with a strong FLT-3 ITD kinase affinity

enthalten in: Cancer letters | 2013

von Rochais, C. | Cresteil, T. | Perri, V. | +4

5

Hydrogenative desulphurization of thienopyrrolizinones : an easy and selective access to (Z)-phenethylidenepyrrolizinones with in vitro cytotoxic activity

enthalten in: European journal of medicinal chemistry | 2010

von Perri, V. | Rochais, C. | Sopkova-de Oliveira Santos, J. | +4

6

Intramolecular cyclisation of β-aryl-β-amino acids in the design of novel heterocyclic systems with therapeutic interest : an unfailing source of diversity

enthalten in: Current medicinal chemistry | 2010

von Rochais, C. | Rault, S. | Dallemagne, P.

7

Synthesis, reactivity and biological evaluation of novel halogenated tripentones

enthalten in: Bioorganic & medicinal chemistry | 2009

von Perri, V. | Rochais, C. | Cresteil, T. | +2

8

Tripentones : a promising series of potent anti-cancer agents

enthalten in: Anti-cancer agents in medicinal chemistry | 2009

von Rochais, C. | Dallemagne, P. | Rault, S.

1
[1]